• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤中化疗诱导的坏死及手术切缘与局部复发的关系

Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.

作者信息

Picci P, Sangiorgi L, Rougraff B T, Neff J R, Casadei R, Campanacci M

机构信息

Laboratory for Oncology Research, Rizzoli Institute, Bologna, Italy.

出版信息

J Clin Oncol. 1994 Dec;12(12):2699-705. doi: 10.1200/JCO.1994.12.12.2699.

DOI:10.1200/JCO.1994.12.12.2699
PMID:7989947
Abstract

PURPOSE AND METHODS

To assess patients with high-grade osteosarcoma treated at our institution for various prognostic factors for the development of local recurrence of disease. Follow-up data were available for all patients and the mean follow-up duration was 65 months in surviving patients.

RESULTS

There were 28 local recurrences in this study (7%). Of these, only three patients (11%) were alive at the most recent follow-up point, 28, 53, and 54 months after local recurrence. None of 59 patients who were treated primarily with a radical amputation and none of 10 who underwent a rotationplasty developed local recurrence. Four of 48 patients (8%) who had wide amputations, one of whom had an intralesional amputation, and 23 of 237 (10%) who had limb-salvage surgery developed locally recurrent disease. Of 237 patients who underwent limb-sparing resection, three prognostic factors for local control were identified. The strongest association with local recurrence was chemotherapy response (P < .0001), followed closely by surgical margins (P = .0001). Older patients were more likely to have locally recurrent disease (P = .033), with each decade of life older than the first decade having a relative risk of 1.5 times greater per decade (SE = 0.16; 95% confidence interval, 0.034 to .0650). Factors that were not associated with local recurrence included sex, date of diagnosis, and anatomic site of disease.

CONCLUSION

Chemotherapy-induced tumor necrosis and surgical margins are important prognostic factors for local control of patients with osteosarcoma.

摘要

目的与方法

评估在我院接受治疗的高级别骨肉瘤患者发生疾病局部复发的各种预后因素。所有患者均有随访数据,存活患者的平均随访时间为65个月。

结果

本研究中有28例局部复发(7%)。其中,在局部复发后最近一次随访时,即28、53和54个月时,只有3例患者(11%)存活。59例主要接受根治性截肢治疗的患者和10例接受旋转成形术的患者均未发生局部复发。48例行广泛截肢的患者中有4例(8%)发生局部复发性疾病,其中1例为病损内截肢,237例行保肢手术的患者中有23例(10%)发生局部复发性疾病。在237例行保肢切除的患者中,确定了3个局部控制的预后因素。与局部复发关联最强的是化疗反应(P < .0001),其次是手术切缘(P = .0001)。老年患者更易发生局部复发性疾病(P = .033),每增加一个十年,相对于第一个十年,局部复发性疾病的相对风险每十年增加1.5倍(标准误 = 0.16;95%置信区间,0.034至0.0650)。与局部复发无关的因素包括性别、诊断日期和疾病的解剖部位。

结论

化疗诱导的肿瘤坏死和手术切缘是骨肉瘤患者局部控制的重要预后因素。

相似文献

1
Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.骨肉瘤中化疗诱导的坏死及手术切缘与局部复发的关系
J Clin Oncol. 1994 Dec;12(12):2699-705. doi: 10.1200/JCO.1994.12.12.2699.
2
Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?对于化疗坏死效果不佳且切缘阳性的骨肉瘤患者,截肢相对于保肢是否具有任何生存益处?
Bone Joint J. 2015 Jan;97-B(1):115-20. doi: 10.1302/0301-620X.97B1.33924.
3
A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.一种用于原发性高级别骨肉瘤手术分期的新系统:伯明翰分类法。
Clin Orthop Relat Res. 2017 Mar;475(3):842-850. doi: 10.1007/s11999-016-4851-y.
4
Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience.
Ann Oncol. 1992 Apr;3 Suppl 2:S23-7. doi: 10.1093/annonc/3.suppl_2.s23.
5
Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?手术切缘是否影响肢体非转移性高级别骨肉瘤的局部复发和生存率?
Clin Orthop Relat Res. 2016 Mar;474(3):677-83. doi: 10.1007/s11999-015-4359-x.
6
Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma.骨肉瘤患者行根治性手术和保肢手术后的局部和全身控制情况。
Clin Orthop Relat Res. 1999 Jan(358):120-7.
7
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.骨肉瘤局部复发的预测因素:540例肢体肿瘤患者在新辅助化疗后至少随访2.5年。
Acta Orthop Scand. 1998 Jun;69(3):230-6. doi: 10.3109/17453679809000921.
8
Surgical outcomes and prognostic factors of non-metastatic radiation-induced sarcoma of bone.非转移性放射性诱导性骨肉瘤的手术治疗效果和预后因素。
Eur J Surg Oncol. 2020 Feb;46(2):293-298. doi: 10.1016/j.ejso.2019.10.036. Epub 2019 Oct 31.
9
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.曾接受强化化疗的小儿骨肉瘤复发患者。
J Clin Oncol. 1994 Dec;12(12):2614-20. doi: 10.1200/JCO.1994.12.12.2614.
10
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.肢体非转移性骨肉瘤的新辅助化疗
Clin Orthop Relat Res. 1991 Sep(270):87-98.

引用本文的文献

1
Advances on immunotherapy for osteosarcoma.骨肉瘤的免疫治疗进展。
Mol Cancer. 2024 Sep 9;23(1):192. doi: 10.1186/s12943-024-02105-9.
2
Endoprosthesis vs. nail-cement spacer application for reconstruction after oncologic proximal humeral resection: is there a difference in functional outcome?肿瘤性肱骨近端切除术后重建采用人工关节置换与髓内钉-骨水泥间隔物植入:功能结果是否存在差异?
JSES Int. 2024 Feb 24;8(4):692-698. doi: 10.1016/j.jseint.2024.01.018. eCollection 2024 Jul.
3
A Se Nanoparticle/MgFe-LDH Composite Nanosheet as a Multifunctional Platform for Osteosarcoma Eradication, Antibacterial and Bone Reconstruction.
载硒纳米颗粒/镁铁水滑石复合纳米片作为一种用于骨肉瘤消除、抗菌和骨重建的多功能平台。
Adv Sci (Weinh). 2024 Sep;11(33):e2403791. doi: 10.1002/advs.202403791. Epub 2024 Jul 3.
4
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics.一种追踪骨肉瘤化疗耐药表型的动态微小RNA谱。对新型疗法的启示。
medRxiv. 2024 Jun 20:2024.06.19.24309087. doi: 10.1101/2024.06.19.24309087.
5
A case report of rib osteosarcoma and literature review.肋骨骨肉瘤病例报告及文献复习。
Clin Respir J. 2023 Nov;17(11):1182-1189. doi: 10.1111/crj.13686. Epub 2023 Sep 14.
6
Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung.骨肉瘤首次转移至骨和肺之间不同的基因组特征。
Heliyon. 2023 Apr 17;9(5):e15527. doi: 10.1016/j.heliyon.2023.e15527. eCollection 2023 May.
7
Development and Validation of a Prognostic Model for Overall Survival in Patients with Primary Pelvis and Spine Osteosarcoma: A Population-Based Study and External Validation.原发性骨盆和脊柱骨肉瘤患者总生存预后模型的开发与验证:一项基于人群的研究及外部验证
J Clin Med. 2023 Mar 27;12(7):2521. doi: 10.3390/jcm12072521.
8
Controversies and Challenges in the Management of Osteosarcoma-an Indian Perspective.骨肉瘤治疗中的争议与挑战——印度视角
Indian J Surg Oncol. 2022 Dec;13(4):939-955. doi: 10.1007/s13193-021-01486-3. Epub 2022 Jan 9.
9
Clinical value of ultrasound for the evaluation of local recurrence of primary bone tumors.超声在评估原发性骨肿瘤局部复发中的临床价值。
Front Oncol. 2022 Sep 15;12:902317. doi: 10.3389/fonc.2022.902317. eCollection 2022.
10
Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.用于预测原发性骨肉瘤患者手术后总生存期的风险分层系统和基于网络的列线图。
Front Public Health. 2022 Aug 5;10:949500. doi: 10.3389/fpubh.2022.949500. eCollection 2022.